Senior insider sale
TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$1.68M
42.75K shares
What this filing means
BAYNES ROY D. plans to sell 42.75K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $1.68M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/14/2026ACC: 0001950047-26-003420
42.75K
Shares to sell
$1.68M
Approx. market value
32.75K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
4/14/2026
32.75KTotal acquired32.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/14/2026 | Stock Option Exercise Cash | 32.75K | — |
| Total | 32.75K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10K
Market value
$330.0K
4/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
32.75K
Market value
$1.35M
4/14/2026
Total
Units
42.75K
Value
$1.68M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/6/2026 | 10K | $330.0K | — | Completed |
| Planned — Approximate Date | ||||
4/14/2026 | 32.75K | $1.35M | NASDAQ | Planned |
| Total | 42.75K | $1.68M | ||